MedTrace Logo

Continuous Versus Cyclic Oral Contraceptives for Endometriosis

NCT02237131 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-09-11

No results posted yet for this study

Summary

To evaluate the efficacy of oral contraceptives in a continuous fashion versus the usual cyclic fashion in the recurrence of endometriosis related symptoms and endometriomas following fertility-sparing surgery.

Conditions

  • Dysmenorrhea
  • Pelvic Pain
  • Dyspareunia
  • Endometrioma

Interventions

DRUG

Oral contraceptives cyclic

tables containing Ethinyl estradiol 0.03mg and drospirenone 3mg will be administered in a cyclic fashion 21 days on 7 days off pill for 6 cycles.

DRUG

Oral contraceptives continuous

Patients will be treated with oral contraceptives containing 0.03mg ethinyl estradiol and 3 mg drospirenone per day in a continuous fashion.

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Principal Investigators

  • Nikos Vlahos, AssProfessor · University of Athens, 2nd Department of Obstetrics and Gynecology

  • Olga Triantafyllidou, MD · University of Athens, 2nd Department of Obstetrics and Gynecology

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-04-30
Completion
2015-12-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02237131 on ClinicalTrials.gov